RP-3 is under clinical development by Replimune and currently in Phase I for Lung Cancer.
Two OTC CGMs Cleared; USPSTF Draft Recs for Osteoporosis; Generic Ozempic in Testing
Abbott announced FDA clearance of two over the counter (OTC) continuous glucose monitoring (CGM) systems: one for adults with type 2 diabetes not on insulin